Toward drug-driven design of topical ocular liposomes: a critical assessment of formulation decisions and ocular outcomes.

Kara M, Durgun ME, Özsoy Y

Open source

DOI
10.1080/17435889.2026.2759728
Published
2026 Nov 10
Container
Nanomedicine (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17435889.2026.2759728,
  title = {Toward drug-driven design of topical ocular liposomes: a critical assessment of formulation decisions and ocular outcomes.},
  author = {Kara M and Durgun ME and Özsoy Y},
  year = {2026},
  journal = {Nanomedicine (London, England)},
  doi = {10.1080/17435889.2026.2759728},
  url = {https://doi.org/10.1080/17435889.2026.2759728}
}

RIS

TY  - JOUR
TI  - Toward drug-driven design of topical ocular liposomes: a critical assessment of formulation decisions and ocular outcomes.
AU  - Kara M
AU  - Durgun ME
AU  - Özsoy Y
PY  - 2026
JO  - Nanomedicine (London, England)
DO  - 10.1080/17435889.2026.2759728
UR  - https://doi.org/10.1080/17435889.2026.2759728
ER  - 

APA

M, K., ME, D., & Y, Ö. (2026). Toward drug-driven design of topical ocular liposomes: a critical assessment of formulation decisions and ocular outcomes.. Nanomedicine (London, England). https://doi.org/10.1080/17435889.2026.2759728

Source records